Delivery Order 36F79721D0169-36C24121F0292
Award Date
9/8/21
Potential Completion Date
10/31/21
Potential Value
$148K
Federal Agency
Veterans Integrated Service Network 1
Awardee
Regeneron Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sleepy Hollow, NY 10591, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Regeneron Pharmaceuticals Inc. for the EVKEEZA drug, with a ceiling value of $494,095.20. The contract was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 1, on November 24, 2021. The contract is a BPA Call with a firm fixed price pricing type and has an ultimate completion date of November 23, 2022. The contract is not set aside and is for civilian use. Regeneron Pharmaceuticals is a for-profit...
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Gilead Sciences Inc., a biopharmaceutical company, for the supply of the COVID-19 antiviral medication Veklury (remdesivir). The order has a firm-fixed price of $155,700.00 and a completion date of October 29, 2021. The contract was awarded on December 9, 2020 and is placed under Gilead's existing General Services Administration (GSA) Multiple Award Schedule contract for...
This is a Delivery Order awarded by the Veterans Integrated Service Network (VISN) 16 of the U.S. Department of Veterans Affairs (VA) to Gilead Sciences Inc. (doing business as Gilead), a prominent biopharmaceutical company. The contract is for the procurement of Veklury (remdesivir), a COVID-19 treatment medication. The contract has a firm fixed price of $77,850.00 and an ultimate completion date of July 18, 2021. The award is not associated with any set-aside designations. Gilead is the...
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Gilead Sciences Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The order is for Veklury (remdesivir) to treat COVID-19, with a potential value of $194,625.00. As a Firm Fixed Price contract, Gilead will deliver the pharmaceutical product directly to VA medical facilities in Carrollton, TX. The award is not associated with a set-aside designation....
The Department of Veterans Affairs Veterans Health Administration awarded a $194,625 firm-fixed-price delivery order to Gilead Sciences Inc. to provide REMDESIVIR 100MG LYOPHILIZED SOLID (COVID-19) under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB). This order was placed under the Department's response to the Coronavirus COVID-19 national emergency. Gilead, a biopharmaceutical company, will deliver the COVID-19 treatment product directly to the VA's facilities...
This is a federal delivery order contract awarded by the Veterans Integrated Service Network 9 (VISN 9), part of the U.S. Department of Veterans Affairs (VA), to Gilead Sciences Inc. for the emergency procurement of the drug remdesivir. The contract has a ceiling value of $77,850.00 and was awarded on January 8, 2021, with a completion date of January 16, 2021. The contract was placed under GSA Schedule 61-IB for Pharmaceuticals and Drugs and utilized a firm fixed-price pricing type. This...
This is a $47,796.92 firm-fixed-price delivery order awarded to Gilead Sciences Inc. (Gilead) by the U.S. Department of Veterans Affairs (VA) for the pharmaceutical product LENACAPAVIR. The order was placed under Gilead's General Services Administration (GSA) Schedule 61-IB contract for Pharmaceuticals and Drugs. Gilead is a biopharmaceutical company that provides a range of critical medications to federal agencies, including antiviral treatments, cancer immunotherapies, and pulmonary...
This is a $93,420.00 firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 7 to ASD Specialty Healthcare, LLC, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of remdesivir, an antiviral medication used for the treatment of COVID-19. This award is a replacement for a previously canceled order due to the incorrect use of fiscal year funds and cost accounting codes. The contract has no set-aside...
This federal contract award is for the delivery of REMDESIVIR 100MG/VIAL INJ to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The contract was awarded to the prime contractor Gilead Sciences Inc., a for-profit biopharmaceutical manufacturer, on December 3, 2020, with a potential value of $140,130.00. The contract has a completion date of December 11, 2020 and is categorized under the Coronavirus COVID-19 National Interest Action Code....
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 to APL Sales I LLC, a subsidiary of Apellis Pharmaceuticals, Inc. The $25,831.04 order is for the delivery of the drug EMPAVELI to VA facilities in Pittsburgh, Pennsylvania. This delivery order falls under APL Sales I LLC's Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, which has a ceiling value of $225,000 and runs through...